Mobile app and provider portal to improve HPV cervical screening in Nicaragua
Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program
This project brings a patient mobile app together with a provider portal to help women in Nicaragua get HPV screening, reminders, results, and timely follow-up.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11161644 on NIH RePORTER |
What this research studies
You would use a smartphone app to receive information about HPV screening, appointment reminders, notifications of results, and guidance for next steps. Local clinics and providers would use a connected portal to track test results, coordinate follow-up, and link women to treatment when needed. The team will adapt the app and portal to fit regional needs through community outreach and navigation support. The program will be rolled out alongside existing HPV primary screening services and monitored for how well it reaches women and helps them get care.
Who could benefit from this research
Good fit: Women in Nicaragua who are eligible for HPV-based cervical cancer screening, especially those with access to a mobile phone, are ideal candidates for participation.
Not a fit: People without reliable mobile phone access, those living outside the program's target regions, or individuals already up-to-date with screening and treatment may not receive direct benefit.
Why it matters
Potential benefit: If successful, the program could make it easier for women to complete HPV screening, get results faster, and receive prompt treatment when needed.
How similar studies have performed: HPV primary screening and community-based screening models have shown success elsewhere, while pairing patient smartphone apps with provider portals for follow-up in this setting is newer and less tested.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Mitchell, Emma Mckim — University of Virginia
- Study coordinator: Mitchell, Emma Mckim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.